Enhancement of human immunodeficiency virus type 1 replication is not intrinsic to all polyanion-based microbicides

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3565-3568

  Sonza, Secondo ^a,b   Johnson, Adam ^a   Tyssen, David ^a   Spelman, Tim ^a   Lewis, Gareth R ^c   Paull, Jeremy R A ^c   Tachedjian, Gilda ^a,b,d  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Starpharma Holdings Limited   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ENFUVIRTIDE; MICROBICIDE; POLYANION; PRO 2000; VIVAGEL;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; NAPHTHALENESULFONATES; PEPTIDE FRAGMENTS; POLYLYSINE; POLYMERS; VIRUS REPLICATION;

EID: 67749110106     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00102-09     Document Type: Article

References (23)

1. Abner, S. R., P. C. Guenthner, J. Guarner, K. A. Hancock, J. E. Cummins, Jr., A. Fink, G. T. Gilmore, C. Staley, A. Ward, O. Ali, S. Binderow, S. Cohen, L. A. Grohskopf, L. Paxton, C. E. Hart, and C. S. Dezzutti. 2005. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J. Infect. Dis. 192:1545-1556.
2. Balzarini, J., and L. Van Damme. 2007. Microbicide drug candidates to prevent HIV infection. Lancet 369:787-797.
3. Bernstein, D. I., L. R. Stanberry, S. Sacks, N. K. Ayisi, Y. H. Gong, J. Ireland, R. J. Mumper, G. Holan, B. Matthews, T. McCarthy, and N. Bourne. 2003. Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob. Agents Chemother. 47:3784-3788.
4. Chen, M. Y., I. Y. Millwood, H. Wand, M. Poynten, M. Law, J. M. Kaldor, S. Wesselingh, C. F. Price, L. J. Clark, J. R. Paull, and C. K. Fairley. 2009. A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis. J. Acquir. Immune Defic. Syndr. 50:375-380.
5. Cummins, J. E., Jr., J. Guarner, L. Flowers, P. C. Guenthner, J. Bartlett, T. Morken, L. A. Grohskopf, L. Paxton, and C. S. Dezzutti. 2007. Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob. Agents Chemother. 51:1770-1779.
6. Dezzutti, C. S., V. N. James, A. Ramos, S. T. Sullivan, A. Siddig, T. J. Bush, L. A. Grohskopf, L. Paxton, S. Subbarao, and C. E. Hart. 2004. In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission. Antimicrob. Agents Chemother. 48:3834-3844.
7. Fletcher, P. S., and R. J. Shattock. 2008. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection. Curr. Opin. Investig. Drugs 9:189-200.
8. Fletcher, P. S., G. S. Wallace, P. M. Mesquita, and R. J. Shattock. 2006. Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology 3:46.
9. Grant, R. M., D. Hamer, T. Hope, R. Johnston, J. Lange, M. M. Lederman, J. Lieberman, C. J. Miller, J. P. Moore, D. E. Mosier, D. D. Richman, R. T. Schooley, M. S. Springer, R. S. Veazey, and M. A. Wainberg. 2008. Whither or wither microbicides? Science 321:532-534.
10. Jagodzinski, P. P., A. Wierzbicki, J. Wustner, Y. Kaneko, and D. Kozbor. 1999. Enhanced human immunodeficiency virus infection in macrophages by high-molecular-weight dextran sulfate is associated with conformational changes of gp120 and expression of the CCR5 receptor. Viral Immunol. 12:23-33.
11. Jiang, Y. H., P. Emau, J. S. Cairns, L. Flanary, W. R. Morton, T. D. McCarthy, and C. C. Tsai. 2005. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retrovir. 21:207-213.
12. Kasahara, K., R. M. Strieter, S. W. Chensue, T. J. Standiford, and S. L. Kunkel. 1991. Mononuclear cell adherence induces neutrophil chemotactic factor/interleukin-8 gene expression. J. Leukoc. Biol. 50:287-295.
13. Kilby, J. M., S. Hopkins, T. M. Venetta, B. DiMassimo, G. A. Cloud, J. Y. Lee, L. Alldredge, E. Hunter, D. Lambert, D. Bolognesi, T. Matthews, M. R. Johnson, M. A. Nowak, G. M. Shaw, and M. S. Saag. 1998. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1302-1307.
14. Lackman-Smith, C., C. Osterling, K. Luckenbaugh, M. Mankowski, B. Snyder, G. Lewis, J. Paull, A. Profy, R. G. Ptak, R. W. Buckheit, Jr., K. M. Watson, J. E. Cummins, Jr., and B. E. Sanders-Beer. 2008. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother. 52:1768-1781.
15. Meylan, P. R., R. S. Kornbluth, I. Zbinden, and D. D. Richman. 1994. Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds. Antimicrob. Agents Chemother. 38:2910-2916.
16. Patton, D. L., Y. T. Cosgrove Sweeney, T. D. McCarthy, and S. L. Hillier. 2006. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob. Agents Chemother. 50:1696-1700.
17. Rupp, R., S. L. Rosenthal, and L. R. Stanberry. 2007. VivaGel (SPL7013 gel): a candidate dendrimer-microbicide for the prevention of HIV and HSV infection. Int. J. Nanomed. 2:561-566.
18. Skoler-Karpoff, S., G. Ramjee, K. Ahmed, L. Altini, M. G. Plagianos, B. Friedland, S. Govender, A. De Kock, N. Cassim, T. Palanee, G. Dozier, R. Maguire, and P. Lahteenmaki. 2008. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 372:1977-1987.
19. Tao, W., C. Richards, and D. Hamer. 2008. Enhancement of HIV infection by cellulose sulfate. AIDS Res. Hum. Retrovir. 24:925-929.
20. Trifonova, R. T., G. F. Doncel, and R. N. Fichorova. 2009. Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses. Antimicrob. Agents Chemother. 53:1490-1500.
21. Turville, S. G., M. Aravantinou, T. Miller, J. Kenney, A. Teitelbaum, L. Hu, A. Chudolij, T. M. Zydowsky, M. Piatak, Jr., J. W. Bess, Jr., J. D. Lifson, J. Blanchard, A. Gettie, and M. Robbiani. 2008. Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. PLoS One 3:e3162.
22. Van Damme, L., R. Govinden, F. M. Mirembe, F. Guedou, S. Solomon, M. L. Becker, B. S. Pradeep, A. K. Krishnan, M. Alary, B. Pande, G. Ramjee, J. Deese, T. Crucitti, and D. Taylor. 2008. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N. Engl. J. Med. 359:463-472.
23. Wapling, J., K. L. Moore, S. Sonza, J. Mak, and G. Tachedjian. 2005. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J. Virol. 79:10247-10257.